Phase 2 Stroke Trial, Recruiting (NCT07406971)

Phase 2 Stroke Trial, Recruiting NCT07406971 Sponsor: Instituto Mexicano del Seguro Social Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07406971 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged between 18 and 80 years old
People who have a stroke severity score (called the NIHSS) between 6 and 20 at the screening assessment
People whose stroke symptoms started within the 24 hours before the study treatment
People who were largely independent before their stroke, with little to no disability beforehand (a pre-stroke mRS score of 1 or less)
People who are able to give written consent themselves, or who have a legally authorised representative who can do so on their behalf

Who may not be able to join:

People who have bleeding in the brain shown on a brain scan
People whose level of consciousness is severely reduced, where the investigator judges that safe participation would not be possible
People whose blood pressure remains above 220/120 mmHg even after initial treatment to bring it down
People who have a serious underlying health condition that, in the investigator's judgement, could interfere with taking part in the study safely

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +524499136423

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07406971

Sponsor: Instituto Mexicano del Seguro Social

Phase: Phase 2

Status: Recruiting

Condition: Stroke

Trial contact: +524499136423

More information: https://clinicaltrials.gov/study/NCT07406971

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged between 18 and 80 years old
People who have a stroke severity score (called the NIHSS) between 6 and 20 at the screening assessment
People whose stroke symptoms started within the 24 hours before the study treatment
People who were largely independent before their stroke, with little to no disability beforehand (a pre-stroke mRS score of 1 or less)
People who are able to give written consent themselves, or who have a legally authorised representative who can do so on their behalf

Who may not be able to join:

People who have bleeding in the brain shown on a brain scan
People whose level of consciousness is severely reduced, where the investigator judges that safe participation would not be possible
People whose blood pressure remains above 220/120 mmHg even after initial treatment to bring it down
People who have a serious underlying health condition that, in the investigator's judgement, could interfere with taking part in the study safely

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Instituto Mexicano del Seguro Social

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

30 September 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Incidence of Adverse Events Within 72 Hours After Administration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov